Dongwoo Khang

4.0k total citations
96 papers, 3.2k citations indexed

About

Dongwoo Khang is a scholar working on Biomedical Engineering, Biomaterials and Immunology. According to data from OpenAlex, Dongwoo Khang has authored 96 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Biomedical Engineering, 26 papers in Biomaterials and 23 papers in Immunology. Recurrent topics in Dongwoo Khang's work include Graphene and Nanomaterials Applications (20 papers), Bone Tissue Engineering Materials (15 papers) and Allergic Rhinitis and Sensitization (13 papers). Dongwoo Khang is often cited by papers focused on Graphene and Nanomaterials Applications (20 papers), Bone Tissue Engineering Materials (15 papers) and Allergic Rhinitis and Sensitization (13 papers). Dongwoo Khang collaborates with scholars based in South Korea, United States and China. Dongwoo Khang's co-authors include Thomas J. Webster, Jing Lu, Karen M. Haberstroh, Chang Yao, Yeon Kyung Lee, Thomas J. Webster, Noel C. MacDonald, Soyoung Lee, Masaru P. Rao and S. Chul Kwon and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Physical review. B, Condensed matter.

In The Last Decade

Dongwoo Khang

89 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongwoo Khang South Korea 31 1.5k 819 659 622 451 96 3.2k
Hang T. Ta Australia 41 1.7k 1.1× 1.3k 1.6× 843 1.3× 951 1.5× 394 0.9× 117 4.3k
Kirsten Peters Germany 37 1.5k 1.0× 1.1k 1.3× 487 0.7× 1.0k 1.6× 1.1k 2.4× 102 4.5k
Wei Wu China 39 1.9k 1.3× 1.8k 2.2× 815 1.2× 1.6k 2.6× 464 1.0× 176 5.6k
Megan S. Lord Australia 37 1.6k 1.0× 1.2k 1.5× 798 1.2× 1.1k 1.7× 461 1.0× 114 4.7k
Hak‐Joon Sung United States 33 2.0k 1.3× 1.5k 1.8× 378 0.6× 878 1.4× 897 2.0× 116 4.1k
Adam C. Midgley China 33 1.1k 0.7× 1.1k 1.4× 661 1.0× 1.2k 1.9× 850 1.9× 88 3.6k
Li Yang China 36 1.2k 0.8× 1.1k 1.4× 473 0.7× 1.1k 1.7× 620 1.4× 145 4.0k
Shuai Shi China 43 1.1k 0.8× 1.7k 2.1× 442 0.7× 1.7k 2.7× 382 0.8× 195 5.9k
Iwona Cicha Germany 37 1.1k 0.7× 1.1k 1.3× 280 0.4× 998 1.6× 616 1.4× 130 4.3k
Sien Lin China 36 1.6k 1.0× 899 1.1× 397 0.6× 1.1k 1.7× 615 1.4× 112 4.1k

Countries citing papers authored by Dongwoo Khang

Since Specialization
Citations

This map shows the geographic impact of Dongwoo Khang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongwoo Khang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongwoo Khang more than expected).

Fields of papers citing papers by Dongwoo Khang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongwoo Khang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongwoo Khang. The network helps show where Dongwoo Khang may publish in the future.

Co-authorship network of co-authors of Dongwoo Khang

This figure shows the co-authorship network connecting the top 25 collaborators of Dongwoo Khang. A scholar is included among the top collaborators of Dongwoo Khang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongwoo Khang. Dongwoo Khang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Jun‐Young, et al.. (2025). Nanocorona-engineered gold nanostars orchestrate photothermal augmented immunotherapy and durable cancer vaccination. Journal of Nanobiotechnology. 23(1). 697–697. 1 indexed citations
2.
Khang, Dongwoo, et al.. (2024). Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier. International Journal of Nanomedicine. Volume 19. 2529–2552. 35 indexed citations
3.
Lee, So-Young, Meiling Jin, Young‐Ae Choi, et al.. (2024). Aspalathin, a Primary Rooibos Flavonoid, Alleviates Mast Cell-Mediated Allergic Inflammation by the Inhibition of FcεRI Signaling Pathway. Inflammation. 48(1). 199–211. 3 indexed citations
5.
Choi, Young‐Ae, Soyoung Lee, Byung-Heon Lee, et al.. (2023). IRF3 Activation in Mast Cells Promotes FcεRI-Mediated Allergic Inflammation. Cells. 12(11). 1493–1493. 3 indexed citations
6.
Lim, Hyoungsub, et al.. (2023). Inflammation‐Targeting Mesenchymal Stem Cells Combined with Photothermal Treatment Attenuate Severe Joint Inflammation. Advanced Materials. 36(11). e2304333–e2304333. 27 indexed citations
7.
Kang, Youn K., et al.. (2023). Drug Repositioning of Metformin Encapsulated in PLGA Combined with Photothermal Therapy Ameliorates Rheumatoid Arthritis. International Journal of Nanomedicine. Volume 18. 7267–7285. 7 indexed citations
8.
Lee, Seunghun, Soyoung Lee, Young‐Ae Choi, et al.. (2022). Portable Cold Atmospheric Plasma Patch‐Mediated Skin Anti‐Inflammatory Therapy. Advanced Science. 9(34). e2202800–e2202800. 18 indexed citations
9.
Choi, Jin Kyeong, Jun‐Young Park, Soyoung Lee, et al.. (2022). Greater Plasma Protein Adsorption on Mesoporous Silica Nanoparticles Aggravates Atopic Dermatitis. International Journal of Nanomedicine. Volume 17. 4599–4617. 10 indexed citations
10.
Lee, Junwoo & Dongwoo Khang. (2022). Mucosal delivery of nanovaccine strategy against COVID-19 and its variants. Acta Pharmaceutica Sinica B. 13(7). 2897–2925. 6 indexed citations
11.
Park, Jun‐Young, Sung Jean Park, Sang‐Hyun Kim, et al.. (2021). Unfolded Protein Corona Surrounding Nanotubes Influence the Innate and Adaptive Immune System. Advanced Science. 8(8). 2004979–2004979. 47 indexed citations
12.
Lee, Soyoung, et al.. (2020). Inhibitory effects of orientin in mast cell-mediated allergic inflammation. Pharmacological Reports. 72(4). 1002–1010. 18 indexed citations
13.
Kim, Sangwoo, Yeon Kyung Lee, Jeong Hee Hong, et al.. (2018). Mutual Destruction of Deep Lung Tumor Tissues by Nanodrug‐Conjugated Stealth Mesenchymal Stem Cells. Advanced Science. 5(5). 1700860–1700860. 29 indexed citations
14.
Kim, Sang‐Woo, Yeon Kyung Lee, Sang‐Hyun Kim, et al.. (2017). Covalent, Non-Covalent, Encapsulated Nanodrug Regulate the Fate of Intra- and Extracellular Trafficking: Impact on Cancer and Normal Cells. Scientific Reports. 7(1). 6454–6454. 24 indexed citations
15.
Kang, Youn Joo, et al.. (2017). Enhanced anti-inflammatory effect of low dose dexamethasone-carbon nanotube conjugates on human arthritis synovial fibroblasts. Osteoarthritis and Cartilage. 25. S416–S416. 2 indexed citations
16.
Kim, Sungwan, Soyoung Lee, Hyun‐Shik Lee, et al.. (2015). Tyrosol Suppresses Allergic Inflammation by Inhibiting the Activation of Phosphoinositide 3-Kinase in Mast Cells. PLoS ONE. 10(6). e0129829–e0129829. 32 indexed citations
17.
Lee, Yeon Kyung, Jin Kyeong Choi, Youn Joo Kang, et al.. (2015). Triamcinolone–carbon nanotube conjugation inhibits inflammation of human arthritis synovial fibroblasts. Journal of Materials Chemistry B. 4(9). 1660–1671. 12 indexed citations
18.
Khang, Dongwoo, et al.. (2014). Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity. International Journal of Nanomedicine. 10. 97–97. 204 indexed citations
19.
Chun, Young Wook, et al.. (2011). Effects of Increasing Carbon Nanofiber Density in Polyurethane Composites for Inhibiting Bladder Cancer Cell Functions. Tissue Engineering Part A. 17(13-14). 1879–1889. 16 indexed citations
20.
Lu, Jing, Dongwoo Khang, & Thomas J. Webster. (2010). Greater endothelial cell responses on submicron and nanometer rough titanium surfaces. Journal of Biomedical Materials Research Part A. 94A(4). 1042–1049. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026